How Often Should Stable NMOSD Patients Get an MRI?
At a Glance
Stable NMOSD does not have one universal MRI schedule. Clinical checkups are usually more important than frequent routine scans, and some consensus guidance suggests a non-contrast brain and spinal cord MRI about every three years; new or worsening symptoms need prompt evaluation.
In this answer
3 sections
If you have been diagnosed with Neuromyelitis Optica Spectrum Disorder (NMOSD) and your condition is currently stable (meaning you have had no recent attacks and no worsening symptoms while on preventive treatment), you may be wondering how often you need an MRI. There is no single universally accepted schedule for routine MRIs in stable NMOSD [1]. However, routine MRIs are recommended much less frequently than in multiple sclerosis (MS) [2]. While MS patients often get annual scans, NMOSD care is highly individualized by your neuroimmunologist (a neurologist specializing in autoimmune diseases of the central nervous system) [3]. As an example of current expert practice, a recent French consensus guideline proposed that for stable patients, a routine surveillance MRI of the brain and spinal cord every 36 months (3 years) may be an appropriate approach [4].
Why NMOSD Monitoring is Different from MS
Because NMOSD is often compared to MS, many patients expect an annual MRI schedule. In multiple sclerosis, the disease often progresses “silently”—meaning new lesions (areas of inflammation or damage) form in the brain or spinal cord without causing obvious symptoms. To catch this silent activity, doctors rely heavily on frequent routine MRIs [5].
NMOSD behaves differently. True “silent progression” (new lesions accumulating without a clinical attack) is much less common in AQP4-positive NMOSD [2][5]. Instead, the vast majority of new permanent neurological injury in NMOSD is driven by active clinical attacks, also known as relapses [6][7].
Because new conventional lesions rarely appear without accompanying physical symptoms, frequent routine MRIs when you feel well are less useful for predicting relapses [1]. While some studies have observed rare instances of silent MRI activity in NMOSD, these findings do not consistently predict when the next attack will happen [8][2]. It is important to note that even without new attacks, patients can still experience persistent daily symptoms, chronic pain, or gradual changes from prior damage, which require ongoing management [9].
The Central Role of Clinical Exams
Because silent lesion accumulation is uncommon, your care team will focus heavily on clinical examinations rather than routine imaging to monitor your stability [6]. Regular check-ins with your doctor provide the most reliable information about how you are doing. A typical clinical visit may include testing your visual acuity, strength, sensation, reflexes, and discussing your bladder and bowel habits.
Your doctor will want to know immediately if you are experiencing any changes in:
- Vision: Blurriness, loss of color vision, or pain with eye movement
- Motor function: Weakness, heaviness, or difficulty walking
- Sensory function: New numbness, tingling, or pain
- Autonomic function: Changes in bladder or bowel habits
- Brainstem symptoms: Unexplained, uncontrollable hiccups, nausea, or vomiting
When Are MRIs Most Important?
While you may not need a routine MRI every year, MRIs remain a critical tool in specific situations [10]. The areas imaged (brain, optic nerves, or spinal cord) and the use of gadolinium (an intravenous contrast dye used to highlight active inflammation) will depend on what your doctor is looking for.
- During Diagnosis: To establish a baseline of your central nervous system and rule out other diseases [4]. Contrast is typically used here to spot active inflammation.
- After Starting Treatment: Some experts recommend a follow-up scan, such as 6 months after diagnosis or after a major treatment change, to ensure the new therapy is working and no new lesions have formed [4].
- Long-Term Surveillance: If you remain clinically stable for a long time, some consensus guidelines suggest a non-contrast scan every 3 years [4]. However, this is not a strict rule, and your doctor will tailor this to your specific antibody status (such as AQP4 or MOG), history, and treatments [3].
- During a Suspected Relapse: If you develop new or worsening neurologic symptoms, an urgent MRI helps your doctor assess for active inflammation and rule out other causes [10].
⚠️ What to Do If Symptoms Appear
Do not wait for an MRI to seek care. Relapse in NMOSD is primarily a clinical diagnosis, meaning your physical symptoms are the most important factor. In some cases, an MRI can be normal or delayed even when a serious attack is happening [10]. If you experience sudden vision loss, new weakness, inability to walk, or persistent vomiting, contact your care team immediately or go to the emergency department.
Additionally, do not try to diagnose a “pseudo-relapse” (a temporary worsening of old symptoms caused by fever, heat, or infection) on your own. While infections can make old symptoms temporarily flare up, any severe or persistent new symptom requires prompt medical evaluation to rule out a true attack and treat any underlying infection [10].
Common questions in this guide
How often should someone with stable NMOSD have an MRI?
Is an annual MRI necessary when NMOSD is stable?
When might I need an MRI after starting or changing NMOSD treatment?
What NMOSD symptoms mean I should seek urgent care instead of waiting for an MRI?
Which parts of the body are included in an NMOSD MRI, and is contrast used?
Can NMOSD have MRI activity without obvious symptoms?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on Neuromyelitis optica spectrum disorder.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my specific antibody status and attack history, what is your recommended schedule for routine MRIs?
- 2.If I experience new or worsening symptoms, what is the exact protocol and phone number to reach the care team after hours?
- 3.At what point should I go directly to the emergency department rather than waiting for an outpatient MRI?
- 4.When we do an MRI, which areas (brain, optic nerves, or spinal cord) will you image, and will you use contrast?
References
References (10)
- 1
Multimodal MRI biomarkers and machine learning in neuromyelitis optica spectrum disorder: a review.
Zhang J, Xu H, Zhao M, et al.
Frontiers in neurology 2026; (17()):1751426 doi:10.3389/fneur.2026.1751426.
PMID: 42682514 - 2
Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
Camera V, Holm-Mercer L, Ali AAH, et al.
JAMA network open 2021; (4(12)):e2137833 doi:10.1001/jamanetworkopen.2021.37833.
PMID: 34878547 - 3
Results of a Survey on Diagnostic Procedures and Treatment Choices for Neuromyelitis Optica Spectrum Disorder in Korea: Beyond the Context of Current Clinical Guidelines.
Lee HL, Kim SH, Seok JM, et al.
Journal of clinical neurology (Seoul, Korea) 2022; (18(2)):207-213 doi:10.3988/jcn.2022.18.2.207.
PMID: 35274837 - 4
MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS.
Durand-Dubief F, Shor N, Audoin B, et al.
Journal of neuroradiology = Journal de neuroradiologie 2025; (52(1)):101235 doi:10.1016/j.neurad.2024.101235.
PMID: 39626832 - 5
Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.
Kang YR, Kim KH, Hyun JW, et al.
Neurology(R) neuroimmunology & neuroinflammation 2026; (13(2)):e200533 doi:10.1212/NXI.0000000000200533.
PMID: 41435220 - 6
Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort.
Gholizadeh S, Exuzides A, Sinnott J, et al.
Scientific reports 2024; (14(1)):26150 doi:10.1038/s41598-024-75013-z.
PMID: 39477975 - 7
Risk factors associated with permanent disability in neuromyelitis optica spectrum disorders.
Valdivia-Tangarife ER, Gamez-Nava JI, Cortés-Enríquez F, et al.
Multiple sclerosis and related disorders 2022; (68()):104114 doi:10.1016/j.msard.2022.104114.
PMID: 36037753 - 8
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Carnero Contentti E, Lopez PA, Tkachuk V, et al.
Multiple sclerosis (Houndmills, Basingstoke, England) 2023; (29(10)):1240-1249 doi:10.1177/13524585231187120.
PMID: 37491849 - 9
Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Masuda H, Mori M, Hirano S, et al.
Journal of neurology, neurosurgery, and psychiatry 2022; (93(1)):32-40 doi:10.1136/jnnp-2021-326386.
PMID: 34362853 - 10
A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.
Solomon JM, Paul F, Chien C, et al.
Therapeutic advances in neurological disorders 2021; (14()):17562864211014389 doi:10.1177/17562864211014389.
PMID: 34035837
This page is for informational purposes only and does not constitute medical advice. Your neuroimmunologist should set your MRI schedule and evaluate any new or worsening symptoms promptly.